Creatine (p = .019) and ALT (p = .052) according to model 2, creatine (p = .042) according to model 3 are clinical factors that increase the risk of diabetes‐related microvascular impairment in the SLF in patients with AD (Table 2). This evidence concerns the gene GPT and Alzheimer disease.